Type 2 diabetes (T2DM), characterized by insulin resistance and impaired insulin secretion, accounts for over 90% of diabetes cases and imposes substantial economic burdens exceeding $1 trillion USD annually in healthcare expenditures (2, 3). This evidence concerns the gene INS and Insulin resistance.